FAKTOR-OPTIONSSCHEIN - INMODE Stock

Certificat

DE000ME283W7

Real-time Bid/Ask 12:28:06 2024-06-28 pm EDT
1.67 EUR / 1.69 EUR +9.80% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
1 month-19.05%
3 months-60.26%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 1.45 -5.23%
24-06-27 1.53 +4.79%
24-06-26 1.46 -7.59%
24-06-25 1.58 -0.63%
24-06-24 1.59 -1.24%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 09:23 am EDT

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN ME283W
ISINDE000ME283W7
Date issued 2023-10-18
Strike 13.55 $
Maturity Unlimited
Parity 2.71 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 13.72
Lowest since issue 1.32
Spread 0.02
Spread %1.19%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.06 USD
Average target price
25.6 USD
Spread / Average Target
+41.75%
Consensus